NCT03665714View on ClinicalTrials.gov

Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer

NACompletedINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

September 21, 2020

Study Completion Date

October 31, 2020

Conditions
Gastrointestinal Cancer
Interventions
OTHER

Impact Oral

Impact Oral belongs to Food for Special Medical Purpose (FSMP) according to China registration regulation, including Omega-3 fatty acids, Arginine and Nucleotides immunonutrition.

OTHER

Enteral Nutrition Emulsion(TPF-T)

TPF-T

Trial Locations (1)

100730

Peiking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT03665714 - Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer | Biotech Hunter | Biotech Hunter